Nevro Corp. Completes Enrollment of US Randomized Pivotal Trial of Novel … – Fort Mills Times

by admin on March 12, 2013

Nevro Corp. Completes Enrollment of US Randomized Pivotal Trial of Novel
Fort Mills Times
Nevro Corp., a medical device company focused on improving pain relief among patients suffering from debilitating chronic pain, today announced completion of enrollment in the SENZA-RCT U.S. pivotal study, designed as the largest prospective,

and more »

View full post on chronic pain – Google News

Previous post:

Next post: